Meanwhile, in non-alcoholic steatohepatitis (NASH), DC including cDC1 increase in the liver and depletion of XCR1+ DC attenuated liver pathology, indicating that XCR1+ DC drive liver pathology in NASH (84). This evidence concerns the gene MPPE1 and metabolic dysfunction-associated steatohepatitis.